| Title |
Recent advances in amyotrophic lateral sclerosis
|
|---|---|
| Published in |
Journal of Neurology, March 2016
|
| DOI | 10.1007/s00415-016-8091-6 |
| Pubmed ID | |
| Authors |
Nilo Riva, Federica Agosta, Christian Lunetta, Massimo Filippi, Angelo Quattrini |
| Abstract |
ALS is a relentlessly progressive and fatal disease, with no curative therapies available to date. Symptomatic and palliative care, provided in a multidisciplinary context, still remains the cornerstone of ALS management. However, our understanding of the molecular mechanisms underlying the disease has advanced greatly over the past years, giving new hope for the development of novel diagnostic and therapeutic approaches. Here, we have reviewed the most recent studies that have contributed to improving both clinical management and our understanding of ALS pathogenesis. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 33% |
| United States | 1 | 33% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 298 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 2 | <1% |
| Portugal | 1 | <1% |
| Chile | 1 | <1% |
| Australia | 1 | <1% |
| Korea, Republic of | 1 | <1% |
| Spain | 1 | <1% |
| Sweden | 1 | <1% |
| Unknown | 290 | 97% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 46 | 15% |
| Student > Master | 40 | 13% |
| Student > Ph. D. Student | 31 | 10% |
| Researcher | 29 | 10% |
| Other | 18 | 6% |
| Other | 57 | 19% |
| Unknown | 77 | 26% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 61 | 20% |
| Agricultural and Biological Sciences | 32 | 11% |
| Neuroscience | 31 | 10% |
| Biochemistry, Genetics and Molecular Biology | 30 | 10% |
| Nursing and Health Professions | 15 | 5% |
| Other | 36 | 12% |
| Unknown | 93 | 31% |
Attention Score in Context
This research output has an Altmetric Attention Score of 21. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 29 March 2023.
All research outputs
#1,584,664
of 23,504,791 outputs
Outputs from Journal of Neurology
#216
of 4,595 outputs
Outputs of similar age
#27,923
of 302,111 outputs
Outputs of similar age from Journal of Neurology
#6
of 89 outputs
Altmetric has tracked 23,504,791 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 4,595 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.2. This one has done particularly well, scoring higher than 95% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 302,111 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 89 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 94% of its contemporaries.